Skip to content
value.today

Cell Source, Inc. vs Zivo Bioscience Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Cell Source, Inc. and Zivo Bioscience Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Jul 30, 2023 for Zivo Bioscience Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet. Zivo Bioscience Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $5 M for Cell Source, Inc. and $13 M for Zivo Bioscience Inc.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

02959881172023Cell Source, Inc. 53Zivo Bioscience Inc. 87

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B2021202220232024Zivo Bioscience Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCell Source, Inc.
CLCS
Zivo Bioscience Inc.
ZIVO
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Revenue—$0 M
Net income$-5 M▲ best$-13 M
Altman Z-score zone——
Data as ofMarket cap Dec 2022; ratios FY2024Market cap Jul 2023; ratios FY2024

Questions and answers#

Which is bigger, Cell Source, Inc. or Zivo Bioscience Inc.?

Cell Source, Inc. and Zivo Bioscience Inc. are worth about the same: $20 M and $20 M (market caps of Dec 25, 2022 for Cell Source, Inc. and Jul 30, 2023 for Zivo Bioscience Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet. Zivo Bioscience Inc.'s value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet.

Which makes more money, Cell Source, Inc. or Zivo Bioscience Inc.?

Both made a net loss: $5 M for Cell Source, Inc. and $13 M for Zivo Bioscience Inc.